Researchers chart a genetic path to diagnosing pulmonary fibrosis and predicting outcomes

Researchers have validated a genetic scoring tool that may help physicians diagnose idiopathic pulmonary fibrosis and identify which patients are at greatest risk for severe outcomes, including death or the need for a lung transplant.

The findings come from a new international study of more than 570,000 people co-led by Mayo Clinic and Brigham and Women's Hospital. ...